Chordia Therapeutics Inc.

TSE:190A Stock Report

Market Cap: JP¥13.9b

Chordia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 190A?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders900,0001.33%
Institutions9,612,80014.2%
Public Companies10,760,50015.9%
General Public18,504,60027.3%
VC/PE Firms27,900,90041.2%

Dilution of Shares: 190A only recently listed within the past 12 months


Top Shareholders

Top 12 shareholders own 75.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
Takeda Pharmaceutical Company Limited
10,760,500JP¥2.2b13.8%no data
11%
Kyoto University Innovation Capital Co., Ltd.
7,408,000JP¥1.5b-6.87%no data
10.7%
Shinsei Capital Partners
7,252,100JP¥1.5b9.9%72.29%
7.47%
Nomura SPARX Investment Inc.
5,052,800JP¥1.0b0%no data
6.22%
SBI Investment Co., Ltd.
4,210,800JP¥867.4m0%5.39%
5.88%
Mitsubishi UFJ Capital Co., Ltd.
3,977,200JP¥819.3m0%5.46%
4.52%
JAFCO Group Co., Ltd.
3,060,400JP¥630.4m-43.9%3.84%
4.5%
SMBC Venture Capital Co., Ltd.
3,046,700JP¥627.6m-23.3%40.04%
3.93%
Nippon Venture Capital Co., Ltd.
2,660,600JP¥548.1m0%10.67%
3.68%
UTokyo Innovation Platform Co., Ltd.
2,492,400JP¥513.4m-26%92.6%
1.33%
Hiroshi Miyake
900,000JP¥185.4m0%no data
0.39%
SBI Holdings Inc., Asset Management Arm
260,900JP¥53.7m0%0.02%